Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: suggest (285), remind (88)

Docetaxel (100) Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER Regimen DOCETAXEL (100) Breast Cancer – Docetaxel (100) Indication Neoadjuvant / adjuvant treatment of breast cancer WHO Performance status
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-100-Ver-11.pdf

Cyclophosphamide-Docetaxel-Doxorubicin Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-DOXORUBICIN Regimen (TAC) Breast Cancer – Cyclophosphamide-Docetaxel-Doxorubicin (TAC) Indication Adjuvant therapy for node positive
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelDoxorubicinTACVer11.pdf

Cyclophosphamide-Docetaxel Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL Regimen Breast Cancer – Cyclophosphamide-Docetaxel Indication Adjuvant therapy for early breast cancer when anthracyclines are
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelVer11.pdf

Having a sialogram - patient information

Description: This factsheet explains what a sialogram is, what to expect at your appointment and what the possible risks are.
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Having-a-sialogram1959-patient-information.pdf

Pertuzumab/Trastuzumab SC

Description: Chemotherapy Protocol BREAST CANCER Regimen Pertuzumab / Trastuzumab SC • Breast Cancer – Trastuzumab / Pertuzumab SC Indication • Treatment of early breast cancer (EBC) in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/PertuzumabTrastuzumab-SC.pdf

Cisplatin and Docetaxel

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN-DOCETAXEL Regimen Uterine-Cisplatin-Docetaxel Indication Recurrent/advanced uterine cancer Palliative intent WHO performance status 0
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/CisplatinDocetaxel.pdf

Olaparib Tablets

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCERS OLAPARIB (tablets) This regimen may require funding. Regimen • Ovarian Cancer – Olaparib (tablets) Indication • Olaparib in its tablet
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Olaparib-Tablets.pdf

InP RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVE) Inpatient Regimen Regimen Lymphoma – InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Indication • Non Hodgkin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab.pdf

Cytoreductive surgery for gynaecological cancer - patient information

Description: This factsheet explains what cytoreductive surgery is, what the procedure involves and what the possible risks are.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Cytoreductive-surgery-for-gynaecological-cancer-3842-PIL.pdf

Docetaxel-Pertuzumab-Trastuzumab Ver 1.3

Description: Chemotherapy Protocol BREAST CANCER DOCETAXEL-PERTUZUMAB-TRASTUZUMAB This protocol may require funding Regimen • Breast Cancer – Docetaxel-Pertuzumab-Trastuzumab Indication • Locally advanced
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-Pertuzumab-Trastuzumab.pdf

61 to 70 of 117

Previous … 5 6 7 8 9 … Next